Application of monoclonal antibody, specific for intracellular Orientia tsutsugamushi, to immunofluorescent antibody test for determining antibiotic susceptibility

Microbiology and Immunology
M K KimJae-Seung Kang

Abstract

The simple quantification of viable intracellular bacteria is important for the study of an obligate intracellular bacterium, Orientia tsutsugamushi. We applied a novel monoclonal antibody (M686-13)--specific for intracellular Orientia--to an immunofluorescent antibody (IFA) test for determining antibiotic susceptibility of O. tsutsugamushi. M686-13 did not react with Orientia that was inhibited by doxycycline, although bacterial particles still remained in the cells. This preferential staining of proliferating bacteria made the IFA test rapid and precise. Using this method, we could successfully measure the minimal inhibitory concentration (MIC) of a Korean strain of O. tsutsugamushi to doxycycline and clindamycin. This method may be used in other procedures to evaluate the growth of Orientia.

References

May 1, 1987·The American Journal of Tropical Medicine and Hygiene·B Hanson
Nov 1, 1988·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·H UrakamiN Kawabata
Aug 1, 1973·Metabolism: Clinical and Experimental·S Reichlin
Sep 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H SongC H Pai
Dec 1, 1995·The American Journal of Tropical Medicine and Hygiene·D J KellyJ N Hershey
Aug 1, 1995·Journal of Korean Medical Science·W H Chang
Jun 1, 1996·Japanese Circulation Journal·M H JeongJ C Kang
Feb 28, 2001·Microbes and Infection·S Y SeongI S Kim
Sep 23, 2003·Current Opinion in Infectious Diseases·George Watt, Philippe Parola

❮ Previous
Next ❯

Citations

Feb 14, 2007·Journal of Korean Medical Science·Mi-Jeong KimJae-Seung Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.